Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Online pharmacy: Why we're offering levonorgestrel EHC for £3

An online pharmacy is hoping to “improve access” to EHC by offering the levonorgestrel pill for £3, while a charity has called for it to be reclassified as a GSL product.

The cost of levonorgestrel-based emergency hormonal contraception (EHC) “can be very low for pharmacies”, which is why an online pharmacy began to supply the levonorgestrel 1.5mg pill for £3 at the start of this week, it told C+D yesterday (November 27).

Dr Fox Pharmacy – which is owned by Index Medical and has its headquarters in Bristol – lists the generic manufactured by Mylan for £3. The product has a Drug Tariff price of £5.20.

“Price and regulatory restrictions” can be a “barrier” for patients seeking emergency contraception, and “improving access…protects against unwanted pregnancy for women who might otherwise be unable to afford it”, Dr Fox Pharmacy told C+D.

Offering EHC at an affordable price “does not encourage risky behaviour”, it stressed. “Women who obtain standby emergency contraception are not being irresponsible, quite the opposite.”

“EHC belongs on pharmacy shelves”

Charity the British Pregnancy Advisory Service (BPAS) said Dr Fox Pharmacy’s decision to supply generic EHC for £3 “illustrates just how cheap this medication is”.

But women are still having to pay “vastly over the odds” – up to £26 – “in their time of need” at “some” pharmacies, the charity claimed.

The BPAS called for progestogen-based EHC to be reclassified from a pharmacy to a general sales list (GSL) product, “so it can be sold directly from the shelf without a consultation, at a more affordable price”.

“We believe emergency contraception belongs on the shelf of the pharmacy, not hidden away at the back, accessible only after a consultation,” the BPAS said.

“The mandatory consultation serves little clinical purpose and can act as a barrier to access,” it added.

Last month, the Company Chemists’ Association and the Association of Independent Multiple Pharmacies called on the government to commission a national EHC service in pharmacies.

Result

Should emergency hormonal contraception (EHC) be reclassified from a pharmacy to a general sales list (GSL) product?
Yes
27%
No
73%
Total votes: 106

Do you think progestogen-based EHC products should be reclassified as GSL items?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD006220

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel